These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The mode of action of cis dichloro-bis (isopropylamine) trans dihydroxy platinum IV (CHIP) studied by the analysis of chromosome aberration production. Bocian E; Laverick M; Nias AH Br J Cancer; 1983 Apr; 47(4):503-9. PubMed ID: 6849795 [TBL] [Abstract][Full Text] [Related]
3. An in vitro study comparing the cytotoxicity of three platinum complexes with regard to the effect of thiol depletion. Smith E; Brock AP Br J Cancer; 1988 Jun; 57(6):548-52. PubMed ID: 3044430 [TBL] [Abstract][Full Text] [Related]
4. The radiomimetic properties of a platinum drug. Barot HA; Laverick M; Nias AH Br J Radiol; 1985 Jan; 58(685):51-62. PubMed ID: 3840711 [TBL] [Abstract][Full Text] [Related]
5. Sister chromatid exchanges induced by two radiosensitizing platinum compounds (cis-dichloro-bis isopropylamine trans dihydroxy platinum IV (CHIP) and cis platinum metronidazole2Cl2(FLAP)) in CHO cells in vitro. Bocian E; Laverick M; Nias AH Br J Cancer; 1983 Dec; 48(6):803-7. PubMed ID: 6652019 [TBL] [Abstract][Full Text] [Related]
6. The mechanism of action of cis-dichloro-bis (isopropylamine) trans dihydroxyplatinum IV (CHIP) on Chinese hamster and C3H mouse tumor cells and its interaction with X-irradiation. Nias AH; Bocian E; Laverick M Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1341-4. PubMed ID: 528286 [No Abstract] [Full Text] [Related]
7. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells. Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368 [TBL] [Abstract][Full Text] [Related]
8. Hypoxic cell sensitization to radiation damage by a new radiosensitizer: cis-dichloro-bis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole-N3)platinum(II) (flap). Bales JR; Sadler PJ; Coulson CJ; Laverick M; Nias AH Br J Cancer; 1982 Nov; 46(5):701-5. PubMed ID: 6890846 [TBL] [Abstract][Full Text] [Related]
9. Effects of cis-platinum(II) diamminedichloride on survival and the rate of DNA synthesis in synchronously growing Chinese hamster V79-379A cells in the absence and presence of caffeine inhibited post-replication repair; evidence for an inducible repair mechanism. Fraval HN; Roberts JJ Chem Biol Interact; 1978 Oct; 23(1):99-110. PubMed ID: 699192 [TBL] [Abstract][Full Text] [Related]
10. Antimitotic and cytotoxic activity of cis-dichlorobis-(cyclohexylamine)platinum(II) on Chinese hamster ovary cells. Celotti L; Furlan D; Brovelli P Chem Biol Interact; 1981 May; 35(2):189-97. PubMed ID: 7194152 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of the radiation response of hypoxic mammalian cells by cis-dichlorobis(isopropylamine)trans-dihydroxy platinum IV (CHIP). Laverick M; Nias AH Br J Radiol; 1981 Jun; 54(642):529-30. PubMed ID: 7237036 [No Abstract] [Full Text] [Related]
12. Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant disease. Thatcher N; Sharma H; Harrison R; Smith A; Zaki A; McAuliffe CA; Crowther D; Fox BW Cancer Chemother Pharmacol; 1982; 9(1):13-6. PubMed ID: 6890414 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer. Pendyala L; Greco W; Cowens JW; Madajewicz S; Creaven PJ Cancer Chemother Pharmacol; 1983; 11(1):23-8. PubMed ID: 6883623 [TBL] [Abstract][Full Text] [Related]
14. The effects of dichloro-trans-dihydroxy-bis-isopropyl-amine-platinum IV on the primary cell-mediated cytotoxic response. Schlaefli E; Ehrke MJ; Mihich E Immunopharmacology; 1983 Aug; 6(2):107-22. PubMed ID: 6224759 [TBL] [Abstract][Full Text] [Related]
15. Cycle-dependent anticancer drug cytotoxicity in mammalian cells synchronized by centrifugal elutriation. Meyn RE; Meistrich ML; White RA J Natl Cancer Inst; 1980 May; 64(5):1215-9. PubMed ID: 6154171 [TBL] [Abstract][Full Text] [Related]
16. Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP). Creaven PJ; Madajewicz S; Pendyala L; Mittelman A; Pontes E; Spaulding M; Arbuck S; Solomon J Cancer Treat Rep; 1983 Sep; 67(9):795-800. PubMed ID: 6883356 [TBL] [Abstract][Full Text] [Related]
17. Criteria for the selection of second-generation platinum compounds. Shepherd R; Kusnierczyk H; Jones M; Harrap KR Br J Cancer; 1980 Nov; 42(5):668-76. PubMed ID: 7193043 [TBL] [Abstract][Full Text] [Related]
18. Studies on the pharmacokinetics and metabolism of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) in the dog. Pendyala L; Cowens JW; Creaven PJ Cancer Treat Rep; 1982 Mar; 66(3):509-16. PubMed ID: 7060038 [TBL] [Abstract][Full Text] [Related]